C.B. Reusken, M. Ieven, L. Sigfrid, I. Eckerle, M. Koopmans 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Twelve years of dengue surveillance in Belgian travellers and significant increases in the number of cases in 2010 and 2013  J. Verschueren, L. Cnops,
P. Melin  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
Malaria in Europe: emerging threat or minor nuisance?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Virological tools to diagnose and monitor hepatitis C virus infection
Refugee crisis and re-emergence of forgotten infections in Europe
R. Cantón  Clinical Microbiology and Infection 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans?  J.-Y. Madec, M. Haenni, P. Nordmann,
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Surveillance of Legionnaires’ disease in Austria
Vector control: a cornerstone in the malaria elimination campaign
Towards the risk of yellow fever transmission in Europe
Training for the infectious diseases speciality in Norway
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Elements of design: the knowledge on which we build
S. Kurath, G. Halwachs-Baumann, W. Müller, B. Resch 
G. Pappas  Clinical Microbiology and Infection 
Acute schistosomiasis, a diagnostic and therapeutic challenge
Metagenomics and probiotics
L. Sigfrid, C. Reusken, I. Eckerle, V. Nussenblatt, S. Lipworth, J
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Previously unknown species of Aspergillus
Laboratory diagnosis of Clostridium difficile disease
The practice of travel medicine in Europe
Sexually acquired Zika virus: a systematic review
Systematic review of antibiotic consumption in acute care hospitals
The role of antimalarial treatment in the elimination of malaria
Abstracts cont. Clinical Microbiology and Infection
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Human cryptosporidiosis in Europe
Vaccinations against respiratory tract infections at Hajj
C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D
Comparison of different methods for identification of species of the genus Raoultella: report of 11 cases of Raoultella causing bacteraemia and literature.
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
C. Gagliotti, L. Nobilio, M.L. Moro 
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
Survival of rhinoviruses on human fingers
F.J. Pastor, J. Guarro  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Impact of antibiotic restrictions: the patient's perspective
The burden of chikungunya in the Pacific
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

Laboratory preparedness and response with a focus on arboviruses in Europe  C.B. Reusken, M. Ieven, L. Sigfrid, I. Eckerle, M. Koopmans  Clinical Microbiology and Infection  Volume 24, Issue 3, Pages 221-228 (March 2018) DOI: 10.1016/j.cmi.2017.12.010 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 An effective laboratory preparedness and response at reference and clinical laboratory level is the basis for the success of a wide spectrum of disease control measures targeting different phases in the development of an arbovirus disease outbreak. (A) Development in time of an arthropod-borne virus enzootic with human spill-over (adapted from [138]). In the case of arbovirus infections that transmit from human-to-human there is no involvement of an animal reservoir (green lines). (B) The three surveillance pyramids involved in the monitoring of arthropod-borne zoonoses (adapted from [139]). In case of a human–mosquito–human transmission there is no involvement of surveillance in animal reservoirs (green pyramid). Early response needs sampling and diagnosis towards the base of the pyramids. (C) Two levels, reference and clinical, of laboratory involvement in three scenarios of disease presence: endemic disease, returning travellers and an emerging infectious disease threat. ‘’x’ indicates involvement of each of the two levels of laboratory response in the three scenarios. ‘X*’ indicates optional role of clinical laboratories in case of common travel-related diseases. Arrows indicate direction of interaction/up-scaling of capacity. Clinical Microbiology and Infection 2018 24, 221-228DOI: (10.1016/j.cmi.2017.12.010) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions